EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis

Kirstine K Rasmussen iD, Wendy Bannister iD, Theis Itenov, Melissa Skeans, Sarah L Pett, Christine Wendt iD, Ken M Kunisaki iD, Gail Matthews, Alexander Jordan iD, Charlotte Suppli Ulrik iD, Therese Lapperre iD, Rasmus Dahlin Bojesen iD und 6 weitere

Open Forum Infectious Diseases · 02.06.2026 · 13 (6)

DOI: 10.1093/ofid/ofag316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 23.06.2026. Verfasst von Kirstine K Rasmussen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, National Institutes of Health, Danish National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza and SARS-CoV-2 can cause severe respiratory failure, but the metabolic pathways that lead to clinical deterioration are not fully uncovered. Tryptophan catabolism has been linked to disease progression and adverse outcomes. We aimed to find out whether the link between tryptophan catabolism and disease progression is shared by the 2 viral infections and, in an exploratory manner, to assess other metabolic pathways.

Methods

Adults hospitalized due to influenza or SARS-CoV-2 from 3 prospective studies were pooled in a nested case-control study design. Cases were defined by disease progression: an increase in oxygen supplementation, intensive care unit admission, or death within 28 days. Cases were matched 1:2 to nonprogressors by pathogen and initial disease severity. We tested associations of plasma kynurenine, tryptophan, and the kynurenine/tryptophan ratio with disease progression. Metabolic profiles were investigated by unsupervised clustering-based, pathway-resolved methods.

Results

We included 303 patients hospitalized with influenza or SARS-CoV-2. Higher levels of kynurenine and higher kynurenine/tryptophan ratios were associated with disease progression (odds ratio per log2 increase [95% CI], 1.81 [1.21–2.70] and 1.89 [1.26–2.84], respectively) independent of pathogen. Two metabolite modules were associated with disease progression. One module contained multiple amino acids, including kynurenine and 10 other tryptophan catabolism metabolites. The other module contained mainly lipids and xenobiotics.

Conclusions

Several groups of metabolites were associated with disease progression independent of the pathogen. This indicates that biological mechanisms related to disease severity are shared in influenza and COVID-19. These mechanisms could be used for risk stratification of patients for potential disease-modifying treatments.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2influenzakynureninemetabolomicstryptophan

Autor:innen und Institutionen

  • Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Anesthesiology and Intensive Care, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
  • MRC Clinical Trials Unit, University College London, London, UK.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Kirstine K Rasmussen, Wendy Bannister, Christine Wendt, Ken M Kunisaki, Alexander Jordan, Charlotte Suppli Ulrik, Therese Lapperre, Rasmus Dahlin Bojesen, Uffe Bodtger, Emma E Ilett, Thomas Benfield, Pradeesh Sivapalan, Jens-Ulrik Stæhr Jensen

Förderung

  • National Cancer Institute
  • National Institutes of Health
  • Danish National Research Foundation
  • Novo Nordisk Foundation

Zitieren

APA

Rasmussen, K. K., Bannister, W., Itenov, T., Skeans, M., Pett, S. L., Wendt, C., Kunisaki, K. M., Matthews, G., Jordan, A., Ulrik, C. S., Lapperre, T., Bojesen, R. D., Bodtger, U., Ilett, E. E., Benfield, T., Sivapalan, P., Murray, D. D., & Jensen, J. S. (2026). Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis. Open Forum Infectious Diseases, 13(6). https://doi.org/10.1093/ofid/ofag316

Vancouver

Rasmussen KK, Bannister W, Itenov T, Skeans M, Pett SL, Wendt C, et al. Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis. Open Forum Infectious Diseases. 2026;13(6). doi:10.1093/ofid/ofag316

BibTeX
@article{Rasmussen2026,
  author = {Rasmussen, Kirstine K and Bannister, Wendy and Itenov, Theis and Skeans, Melissa and Pett, Sarah L and Wendt, Christine and Kunisaki, Ken M and Matthews, Gail and Jordan, Alexander and Ulrik, Charlotte Suppli and Lapperre, Therese and Bojesen, Rasmus Dahlin and Bodtger, Uffe and Ilett, Emma E and Benfield, Thomas and Sivapalan, Pradeesh and Murray, Daniel D and Jensen, Jens-Ulrik Stæhr},
  title = {Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {6},
  doi = {10.1093/ofid/ofag316}
}
Kostenlos starten →